News for Frontage Holdings Corporation (1521.HK)

PR NewswireEXTON, Pa., June 2, 2025 EXTON, Pa., June 2, 2025 /PRNewswire/ -- Frontage Laboratories, Inc. officially unveiled its newest Contract Research,

EXTON, PA / ACCESSWIRE / January 13, 2025 / Frontage Holdings Corporation (SEHK stock code:1521) announced on January 6 2025 that Dr. Abdul Mutlib has decided t

EXTON, Pa., Feb. 1, 2024 /PRNewswire/ -- Frontage Holdings Corporation is pleased to announce that Mr. Henry Gao has been appointed as its Chief Financial Officer , effective February 1, 2024. ...

The global contract research organization (CRO) services market is anticipated to depict a 12.1% CAGR through the estimated period. Crucial factors...

/PRNewswire/ -- The

/PRNewswire/ -- The "Global Drug Discovery Services Market by Process (Target Selection, Hit-to-lead), Type (Chemistry, Biology), Drug Type (Small Molecule,...

/PRNewswire/ -- Frontage Holdings Corporation today announced that Dr. Abdul Mutlib has been promoted to CEO of the company, a role in which he succeeds...

/PRNewswire/ -- Frontage Holdings Corporation ("Frontage"), a contract research organization ("CRO") providing integrated, science-driven research, analytical,...

/PRNewswire/ -- Frontage Laboratories, Inc. is pleased to announce the opening of a custom-built 19,000 square foot laboratory located at 3801 Bay Center...

/PRNewswire/ -- Frontage Laboratories, Inc. ("Frontage") completed the acquisition of Frontage Clinical Services Inc. ("Frontage Clinical"), a clinical Phase...